Stem cell treatment offers new hope for diabetics
Published: 02:08 PM,Aug 23,2020 | EDITED : 11:04 AM,Apr 27,2024
A new technique that grows insulin-producing cells and can protect them from immune attack after they are transplanted may offer new hope for treating some people with diabetes.
In type-1 diabetes, the body turns on itself and attacks the so-called beta cells inside clusters in the pancreas called 'islets'.
These beta cells are responsible for gauging sugar levels in the blood and releasing insulin to keep them stable. Without them, diabetics must rely on insulin injections or pumps.
One treatment devised to end that reliance involves transplanting donor islets into diabetics, but the process is complicated by several obstacles, including a shortage of donors.
As a result, patients have to take drugs that suppress their immune systems, protecting their transplant but potentially exposing the rest of their body to illness.
In a bid to overcome some of these challenges, a team looked to find another source for islets, by coaxing induced pluripotent stem cells (iPS) to produce what the team called HILOs, or human islet-like organoids.
These HILOs, when grown in a 3D environment mimicking the pancreas and then turbocharged with a 'genetic switch', successfully produced insulin and were able to regulate blood glucose when transplanted into diabetic mice.
'In the past, this functionality was only achieved after a month-long maturation in a living animal,' said Ronald Evans, director of the Gene Expression Lab at the Salk Institute for Biological Studies.
'This breakthrough allows for the production of functional HILOs which are active on the first day of transplantation, placing us closer to clinical applications,' Evans, who led the study, told AFP.
Islets also often fail to connect with blood supply, and even when they do, like other transplants, they can come under attack by the recipient's immune system, which views the cells as invaders.
- Giving hope -